Cite

    Colice, G. (2014). For patients with chronic asthma not controlled with inhaled corticosteroids alone, long-acting β-agonists are associated with fewer exacerbations than leukotriene receptor agonists. Evidence-based medicine. 19 (5), p. 174. [Online].